MicroRNA-125b protects against myocardial ischaemia/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6

Cardiovascular Research

Volumn 102, Issue 3, 2014, Pages 385-395

  Wang, Xiaohui ^a   Ha, Tuanzhu ^a   Zou, Jianghuan ^b   Ren, Danyang ^a   Liu, Li ^c   Zhang, Xia ^a   Kalbfleisch, John ^a   Gao, Xiang ^b   Williams, David ^a   Li, Chuanfu ^a  

^a East Tennessee State University   (United States)

^b NANJING UNIVERSITY   (China)

^c NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; MicroRNA 125b; Myocardial I R; NF B; p53

Indexed keywords

CASPASE 3; CASPASE 7; CASPASE 8; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LENTIVIRUS VECTOR; MICRORNA 125B; PROTEIN BAK; PROTEIN P53; TRIPHENYLTETRAZOLIUM; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; BAK1 PROTEIN, MOUSE; CASPASE; MICRORNA; MIRN125 MICRORNA, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMMON CAROTID ARTERY; CONTROLLED STUDY; ECHOCARDIOGRAPHY; GENETIC TRANSFECTION; HEART EJECTION FRACTION; HEART FUNCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; STAINING; VECTOR CONTROL; WESTERN BLOTTING; ANIMAL; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; CELL CULTURE; GENETICS; HEART INFARCTION; HEART MUSCLE; HEART MUSCLE CELL; LENTIVIRINAE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; NEUTROPHIL CHEMOTAXIS; PATHOLOGY; PHYSIOLOGY;

ANIMALS; APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASPASES; CELLS, CULTURED; LENTIVIRUS; MALE; MICE; MICE, INBRED C57BL; MICRORNAS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NEUTROPHIL INFILTRATION; NF-KAPPA B; RATS; SIGNAL TRANSDUCTION; TNF RECEPTOR-ASSOCIATED FACTOR 6; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84901398552     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvu044     Document Type: Article

References (42)

1. Linde A, Mosier D, Blecha F, Melgarejo T. Innate immunity and inflammation-new frontiers in comparative cardiovascular pathology. Cardiovasc Res 2007;73: 26-36.
2. Li C, Ha T, Kelley J, Gao X, Qiu Y, Kao RL, BrowderW, Williams DL. Modulating Toll-like receptor mediated signaling by (1-.3)-b-D-glucan rapidly induces cardioprotection. Cardiovasc Res 2003;61: 538-547.
3. Hua F, Ha T, Ma J, Li Y, Kelley J, Gao X, Browder IW, Kao RL, William DL, Li C. Protection against myocardial ischemia/reperfusion injury in TLR4 deficient mice is mediated through a phosphoinositide 3-kinase dependent mechanism. J Immunol 2007;178: 7317-7324.
4. Oyama J, Blais C Jr, Liu X, Pu M, Kobzik L, Kelly RA, Bourcier T. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004;109: 784-789.
5. Li C, BrowderW, Kao RL. Early activation of transcription factor NF-kB during ischemia in perfused rat heart. Am J Physiol 1999;276: H543-H552.
6. Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, Ogihara T. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997;3: 894-899.
7. Taganov KD, Boldin MP, Chang K-J, Baltimore D. NF-kB-dependent induction of micro-RNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006;103: 12481-6.
8. Ma X, Buscaglia LEB, Barker JR, Li Y. MicroRNAs in NF-kB signaling. J Mol Cell Biol 2011;3: 159-166.
9. Sheedy FJ, O'Neill LAJ. Adding fuel to fire: MicroRNAs as a new class of mediators of inflammation. Ann Rheum Dis 2008;67: Iii50-iii55.
10. Taganov KD, Boldin MP, Baltimore D. MicroRNAs and immunity: Tiny players in a big field. Immunity 2007;26: 133-137.
11. Sonkoly E, Stahle M, Pivarcsi A. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflammation. Semin Cancer Biol 2008;18: 131-140.
12. van Rooij E, Marshall WS, Olson EN. Toward microRNA-based therapeutics for heart disease: The sense in antisense. Circ Res 2008;103: 919-928.
13. Schroen B, Heymans S. MicroRNAs and beyond: The heart reveals its treasures. Hypertension 2009;54: 1189-1194.
14. Fishtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, Weber M, HammCW, RöxeT, Müller-Ardogan M, Bonauer A, Zeiher AM, Dimmeler S. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010;107: 677-684.
15. Dong S, Cheng Y, Yang J, Li J, Liu X, Wang X, Wang D, Krall TJ, Delphin ES, Zhang C. MicroRNA expression signature and the role of microRNA-21 in the early phase of acute myocardial infarction. J Biol Chem 2009;284: 29514-29525.
16. Wang X, Ha T, Liu L, Zou J, Zhang X, Kalbfleisch J, Gao X, Williams D, Li C. Increased expression of microRNA-146a decreases myocardial ischemia/reperfusion injury. Cardiovasc Res 2013;97: 432-442.
17. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993;75: 843-854.
18. Tili E, Michaille JJ, Cimino A, Costinean S, Dumitru CD, Adair B, Fabbri M, Alder H, Liu CG, Calin GA, Croce CM. Modulation of miR-155 and miR-125b levels following lipopolysaccharide/TNF-alpha stimulation and their possible roles in regulating the response to endotoxin shock. J Immunol 2007;179: 5082-5089.
19. Androulidaki A, Iliopoulos D, Arranz A, Doxaki C, Schworer S, Zacharioudaki V, Margioris AN, Tsichlis PN, Tsatsanis C. The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 2009;31: 220-231.
20. Le MTN, Teh C, Shyh-Chang N, Xie H, Zhou B, Korzh V, Lodish HF, Lim B. MicroRNA-125b is a novel negative regulator of p53. Genes Dev 2009;23: 862-876.
21. Le MTN, Shyh-Chang N, Khaw SL, Chin L, Teh C, Tay J, O'Day E, Korzh V, Yang H, Lal A, Lieberman J, Lodish HF, Lim B. Conserved regulation of p53 network dosage by microRNA-125b occurs through evolving miRNA-target gene pairs. PLoS Genet 2011; 7: E1002242.
22. Vaseva AV, Moll UM. The mitochondrial p53 pathway. Biochim Biophys Acta 2009;1787: 414-420.
23. ZhouM, Liu Z, ZhaoY, DingY, Liu H, XiY, XiongW, LiG, Lu J, Fodstad O, Riker AI, TanM. MicroRNA-125b confers the resistance of breast cancer cells to paclitaxel through suppression of pro-apoptotic Bcl-2 antagonist kiler 1 (BAK1) expression. J Biol Chem 2010; 285: 21496-21507.
24. Matsusaka H, Ide T, Matsushima S, Ikeuchi M, Kubota T, Sunagawa K, Kinugawa S, Tsutsui H. Targeted deletion of p53 prevents cardiac rupture after myocardial infarction in mice. Cardiovasc Res 2006;70: 457-465.
25. Ren D, Wang X, Ha T, Liu L, Kalbfleisch J, Gao X, Williams D, Li C. SR-A deficiency reduces myocardial ischemia/reperfusion injury; involvement of increased microRNA-125b expression in macrophages. Biochim Biophys Acta 2012;1832: 336-346.
26. Huang HC, Yu HR, Huang LT, Huang HC, Chen RF, Lin IC, Ou CY, Hsu TY, Yang KD. miRNA-125b regulates TNF-a production in CD14+ neonatal monocytes via posttranscriptional regulation. J Leukocyte Biol 2012;92: 171-182.
27. Deacon RM, Bannerman DM, Kirby BP, Croucher A, Rawlins JN. Effects of cytotoxic hippocampal lesions in mice on a cognitive test battery. Behav Brain Res 2002;133: 57-68.
28. Ha T, Hu Y, Liu L, Lu C, McMullen JR, Kelley J, Kao RL, Williams DL, Gao X, Li C. TLR2 ligands induce cardioprotection against ischemia/reperfusion injury through a PI3K/Aktdependent mechanism. Cardiovasc Res 2010;87: 694-703.
29. O'Connell TD, Rodrigo MC, Simpson PC. Isolation and culture of adult mouse cardiac myocytes. Methods Mol Biol 2007;357: 271-296.
30. Soleimani M, Nadri S. A protocol for isolation and culture of mesenchymal stem cells from mouse bone marrow. Nat Protoc 2009;4: 102-106.
31. Szatkowski ML, Westfall MV, Metzger JM. Direct gene transfer to the adult rodent myocardium in vivo. Methods Mol Biol 2003;219: 195-202.
32. Ha T, Hua F, Liu X, Ma J, McMullen JR, Shioi T, Izumo S, Kelley J, Gao X, Browder W, Williams DL, Kao RL, Li C. Lipopolysaccharide-induced myocardial protection against ischemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism. Cardiovasc Res 2008;78: 546-553.
33. Lu C, Hua F, Liu L, Ha T, Kalbfleisch J, Schweitzer J, Kelley J, Kao R, Williams D, Li C. Scavenger receptor class-A has a central role in cerebral ischemia/reperfusion injury. J Cereb Blood Flow Metab 2010;30: 1972-1981.
34. Gao M, Ha T, Zhang X, Liu L, Wang X, Kelley J, Singh K, Kao R, Gao X, Williams D, Li C. Toll-like receptor 3 plays a central role in cardiac dysfunction during polymicrobial sepsis. Crit Care Med 2012;40: 2390-2399.
35. Munoz C, Pascual-Salcedo D, Castellanos MC, Alfranca A, Aragones J, Vara A, Redondo JM, de Landázuri MO. Pyrrolidine dithiocarbamate inhibits the production of interleukin-6, interleukin-8, and granulocyte-macrophage colony-stimulating factor by human endothelial cells in response to inflammatory mediators: Modulation of NF-kappa B and AP-1 transcription factors activity. Blood 1996;88: 3482-3490.
36. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 1997;388: 394-397.
37. van Empel VPM, Bertrand ATA, Hofstra L, Grijns HJ, Doevendans PA, De Windt LJ. Myocyte apoptosis in heart failure. Cardiovasc Res 2005;67: 21-29.
38. Narula J, Hajjar RJ, Dec GW. Apoptosis in the failing heart. Cardiol Clin 1998;16: 691-710, ix.
39. Lagos-Quintana M, Rauhut R, Yalcin A, Meyer J, LendeckelW, Tuschi T. Identification of tissue-specific microRNAs from mouse. Curr Biol 2002;12: 735-739.
40. Murphy AJ, Guyre PM, Pioli PA. Estradiol suppresses NF-kappa B activation through coordinated regulation of let-7a and miR-125b in primary human macrophages. J Immunol 2010;184: 5029-5037.
41. Rajaram MV, Ni B, Morris JD, Brooks MN, Carlson TK, Bakthavachalu B, SchoenbergDR, Torrelles JB, Schlesinger LS. Mycobacterium tuberculosis lipomannan blocks TNF biosynthesis by regulating macrophage MAPK-activated protein kinase 2 (MK2) and micro-RNA miR-125b. Proc Natl Acad Sci USA 2011;108: 17408-17413.
42. Zhang G, Ghosh S. Toll-like receptor-mediated NF-kB activation: A phylogenetically conserved paradigm in innate immunity. J Clin Invest 2001;107: 13-19.